4 results for author:"Prowse A." in Literature citations
Results Customize
› Repeat search in UniProtKB (3)
| OVCA2 is downregulated and degraded during retinoid-induced apoptosis. Prowse A.H., Vanderveer L., Milling S.W., Pan Z.Z., Dunbrack R.L., Xu X.X., Godwin A.K. Int. J. Cancer 99:185-192(2002) · UniProtKB (1) |
| Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells. Bruening W., Prowse A.H., Schultz D.C., Holgado-Madruga M., Wong A., Godwin A.K. Cancer Res. 59:4973-4983(1999) · UniProtKB (1) |
| Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas. Eng C., Crossey P.A., Mulligan L.M., Healey C.S., Houghton C., Prowse A., Chew S.L., Dahia P.L.M., O'Riordan J.L.H., Toledo S.P.A. et al. J. Med. Genet. 32:934-937(1995) · UniProtKB (1) |
| Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Crossey P.A., Richards F.M., Foster K., Green J.S., Prowse A., Latif F., Lerman M.I., Zbar B., Affara N.A., Ferguson-Smith M.A. et al. Hum. Mol. Genet. 3:1303-1308(1994) · UniProtKB (1) |